Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

By Persiani Roberto  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1077-1079

Springer Publishing Company

Access to resources Recommend Favorite

Ductal carcinoma in situ: how should we treat it?

By Bayraktar Soley   Arun Banu   Glück Stefan  

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 245-256

Future Medicine

Access to resources Recommend Favorite

How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide

By McKay Andrew  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite

Dissemination research in cancer control: where are we and where should we go?

By Bowen Deborah  

Cancer Causes and Control, Vol. 20, Iss. 4, 2009-05 ,pp. : 473-485

Springer Publishing Company

Access to resources Recommend Favorite

How can we improve the quality of reporting family history in colorectal cancer care? (And why does it matter?)

By Wilson Brenda J  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 99-102

Future Medicine

Access to resources Recommend Favorite